TY - JOUR
T1 - Comorbidity Management in Black Women Diagnosed with Breast Cancer
T2 - the Role of Primary Care in Shared Care
AU - Doose, Michelle
AU - Steinberg, Michael B.
AU - Xing, Cathleen Y.
AU - Lin, Yong
AU - Cantor, Joel C.
AU - Hong, Chi Chen
AU - Demissie, Kitaw
AU - Bandera, Elisa V.
AU - Tsui, Jennifer
N1 - Publisher Copyright:
© 2020, Society of General Internal Medicine (This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply).
PY - 2021/1
Y1 - 2021/1
N2 - Background: Black women are more likely to have comorbidity at breast cancer diagnosis compared with White women, which may account for half of the Black-White survivor disparity. Comprehensive disease management requires a coordinated team of healthcare professionals including primary care practitioners, but few studies have examined shared care in the management of comorbidities during cancer care, especially among racial/ethnic minorities. Objective: To examine whether the type of medical team composition is associated with optimal clinical care management of comorbidities. Design: We used the Women’s Circle of Health Follow-up Study, a population-based cohort of Black women diagnosed with breast cancer. The likelihood of receiving optimal comorbidity management after breast cancer diagnosis was compared by type of medical team composition (shared care versus cancer specialists only) using binomial regression. Participants: Black women with a co-diagnosis of diabetes and/or hypertension at breast cancer diagnosis between 2012 and 2016 (N = 274). Main Measures: Outcome—optimal clinical care management of diabetes (i.e., A1C test, LDL-C test, and medical attention for nephropathy) and hypertension (i.e., lipid screening and prescription for hypertension medication). Main predictor—shared care, whether the patient received care from both a cancer specialist and a primary care provider and/or a medical specialist within the 12 months following a breast cancer diagnosis. Key Results: Primary care providers were the main providers involved in managing comorbidities and 90% of patients received shared care during breast cancer care. Only 54% had optimal comorbidity management. Patients with shared care were five times (aRR: 4.62; 95% CI: 1.66, 12.84) more likely to have optimal comorbidity management compared with patients who only saw cancer specialists. Conclusions: Suboptimal management of comorbidities during breast cancer care exists for Black women. However, our findings suggest that shared care is more beneficial at achieving optimal clinical care management for diabetes and hypertension than cancer specialists alone.
AB - Background: Black women are more likely to have comorbidity at breast cancer diagnosis compared with White women, which may account for half of the Black-White survivor disparity. Comprehensive disease management requires a coordinated team of healthcare professionals including primary care practitioners, but few studies have examined shared care in the management of comorbidities during cancer care, especially among racial/ethnic minorities. Objective: To examine whether the type of medical team composition is associated with optimal clinical care management of comorbidities. Design: We used the Women’s Circle of Health Follow-up Study, a population-based cohort of Black women diagnosed with breast cancer. The likelihood of receiving optimal comorbidity management after breast cancer diagnosis was compared by type of medical team composition (shared care versus cancer specialists only) using binomial regression. Participants: Black women with a co-diagnosis of diabetes and/or hypertension at breast cancer diagnosis between 2012 and 2016 (N = 274). Main Measures: Outcome—optimal clinical care management of diabetes (i.e., A1C test, LDL-C test, and medical attention for nephropathy) and hypertension (i.e., lipid screening and prescription for hypertension medication). Main predictor—shared care, whether the patient received care from both a cancer specialist and a primary care provider and/or a medical specialist within the 12 months following a breast cancer diagnosis. Key Results: Primary care providers were the main providers involved in managing comorbidities and 90% of patients received shared care during breast cancer care. Only 54% had optimal comorbidity management. Patients with shared care were five times (aRR: 4.62; 95% CI: 1.66, 12.84) more likely to have optimal comorbidity management compared with patients who only saw cancer specialists. Conclusions: Suboptimal management of comorbidities during breast cancer care exists for Black women. However, our findings suggest that shared care is more beneficial at achieving optimal clinical care management for diabetes and hypertension than cancer specialists alone.
KW - breast cancer
KW - comorbidity
KW - patient care
KW - practice guideline
KW - shared care
UR - http://www.scopus.com/inward/record.url?scp=85091483884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091483884&partnerID=8YFLogxK
U2 - 10.1007/s11606-020-06234-x
DO - 10.1007/s11606-020-06234-x
M3 - Article
C2 - 32974725
AN - SCOPUS:85091483884
SN - 0884-8734
VL - 36
SP - 138
EP - 146
JO - Journal of General Internal Medicine
JF - Journal of General Internal Medicine
IS - 1
ER -